Bullous Pemphigoid Market is segmented By Drug Type (Small Molecules, Biologics), By Route of Administration (Oral, Intravenous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
The major players operating in the bullous pemphigoid market include GlaxoSmithKline, Novartis, Pfizer, AstraZeneca and Roche.
Bullous Pemphigoid Market